Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post-hoc analysis of a phase 3, open-label study.
David G VosslerWilliam E RosenfeldSean SternClarence T WadeLouis FerrariWesley T KerrRobert WechslerPublished in: Epilepsia (2023)
Adjunctive treatment with cenobamate led to sustained seizure reductions during the maintenance phase of the phase 3 safety study.